Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Prolactin affects when mice shed and grow hair.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Different sPLA2 enzymes have unique roles in phospholipid metabolism and biological processes.

Researchers found several compounds that could potentially treat Zika virus.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

PP-PTKL may help treat hair greying, but more testing is needed.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Polygonum multiflorum may treat hair loss by reducing inflammation and stress, and boosting melanin.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Careful management of blood thinners is crucial for lupus patients with APS.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

MIR135b affects wound healing by targeting genes, and PDRN may help heal wounds by altering this pathway.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Prolactin affects when mice shed and grow hair.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Ruxolitinib can help regrow hair in severe alopecia areata.